2096:HKG
Simcere Pharmaceutical Group Ltd
HK$11.05
arrow_downward
-1.52%(-0.17) 1D
Sep 11, 4:08:54 PM GMT+8 · HKD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 2096...
Open
HK$11.17
High
HK$11.20
Low
HK$10.93
Mkt. cap
28.95B
Avg. vol.
0.00
Volume
7.76M
Dividend
1.87%
Quarterly dividend
HK$0.05
Ex-dividend date
Jun 17, 2026
P/E ratio
16.64
52-wk high
HK$14.38
52-wk low
HK$9.07
EPS
HK$0.66
Shares outstanding
2.57B
No. of employees
7K
Open
HK$11.17
High
HK$11.20
Low
HK$10.93
Mkt. cap
28.95B
Avg. vol.
0.00
Volume
7.76M
Dividend
1.87%
Quarterly dividend
HK$0.05
Ex-dividend date
Jun 17, 2026
P/E ratio
16.64
52-wk high
HK$14.38
52-wk low
HK$9.07
EPS
HK$0.66
Shares outstanding
2.57B
No. of employees
7K
Profile
Simcere Pharmaceutical Group or Simcere Pharmaceutical is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market. Its focus is to introduce generic and pharmaceutical products for the treatment of diseases with high incidence and/or mortality rate. The company has introduced a generic anti-stroke medication under the brand name, Bicun, and an anti-cancer medication under the brand name, Endu. Its products include antibiotics, anti-stroke medications, anti-inflammatory drugs, anti-cancer medications and other medicines. In addition, it has obtained approvals from the China State Food and Drug Administration to manufacture and sell over 210 other products. Wikipedia
About Simcere Pharmaceutical Group Ltd
CEORen Jinsheng
Employees7.06K
Founded1995
HeadquartersNanjing, Jiangsu, China
SectorPharmaceutical industry
Websitesimcere.com